Catalyst Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors
I'm PortAI, I can summarize articles.
Catalyst Pharmaceuticals Inc. (CPRX) shares fell 7.23% to $23.08 on Friday, ending a three-day winning streak amid a broader market decline, with the NASDAQ down 0.92% and the Dow Jones down 1.05%. The stock is now 13.17% below its 52-week high of $26.58. In contrast, competitors like Johnson & Johnson, Pfizer, and Abbott Laboratories saw gains. Trading volume reached 1.7 million, surpassing the 50-day average of 1.2 million.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments